Who founded SOLA Biosciences?

SOLA Biosciences was founded by Keizo Koya, Akinori Hishiya in 2016.

Who are SOLA Biosciences's investors?

SOLA Biosciences's investors include Eisai Innovation, Inc., MC Healthcare Ventures, UTEC.

Where is SOLA Biosciences headquartered?

SOLA Biosciences is headquartered in Boston, US.

SOLA Biosciences

Boston, US · Founded 2016 · 4 employees on LinkedIn · 3 known investors

Find your way into SOLA Biosciences

16 people in our graph share verified history with the SOLA Biosciences team — schools, employers, funds. One of them is your warm intro.

Carrie Williamsunlockedknows Keizo Koya · together at Synta Pharmaceuticals (overlapped)

×2knows the team · via SOLA Biosciences

×7knows the team · via Kyushu University

×2knows the team · via Shionogi & Co., Ltd

SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.

Biotech Deep Tech Medical Devices

Founders & leadership

SOLA Biosciences was founded in 2016 by Keizo Koya and Akinori Hishiya.

Keizo Koya inFounder and CEOKeizo Koya has spent over four decades in pharmaceutical research and development across the U.S. and Japan, with training in synthetic organic chemistry and biology. He has led drug development programs spanning oncology, neurodegeneration, autoimmune, and metabolic diseases across small molecules, biologics, and gene therapies, and has founded multiple biotech ventures.

Akinori HishiyainFounder and CSF

Investors · 3

Eisai Innovation, Inc.San Francisco

MC Healthcare VenturesCambridge

UTECTokyo · $3.1M – $78M

In the news

Interview with SOLA Biosciences: How They Secured 26 Investor Meetings at Digital RESI Aprilblog.lifesciencenation.com · May 2020

Frequently asked questions

What does SOLA Biosciences do?: SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins. The company uses its proprietary JUMP70 platform to restore protein homeostasis and deliver disease-modifying treatments.
Who founded SOLA Biosciences?: SOLA Biosciences was founded by Keizo Koya, Akinori Hishiya in 2016.
Who are SOLA Biosciences's investors?: SOLA Biosciences's investors include Eisai Innovation, Inc., MC Healthcare Ventures, UTEC.
Where is SOLA Biosciences headquartered?: SOLA Biosciences is headquartered in Boston, US.